Tharimmune, Inc.

Public

Tharimmune, Inc. is now publicly traded

The data on this page reflects Tharimmune, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Nov 6, 2025

Total Funding Raised

$540M

Company Overview

Tharimmune, Inc. is a clinical-stage biotechnology company that develops a portfolio of therapeutic candidates for inflammatory and immunologic conditions and also operates a digital asset treasury strategy.

AI Layer

Non-AI

Keywords

digital asset treasuryTH104Canton Networknalmefene buccal filmchronic pruritusprimary biliary cholangitisPBCblockchain validatorCanton Coinopioid exposure prophylaxisclinical-stage biotechdrug developmentinstitutional blockchaintransmucosal buccal filmimmuno-oncology platformautoimmune diseasesantibody-drug conjugatesADCsoral anti-TNF biologic

Tharimmune, Inc. Comparables

Compare Tharimmune, Inc. with similar companies based on industry and business-model similarity.

Tharimmune, Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Attovia Therapeutics	59%
ItchBio	59%
Sorriso Pharmaceuticals	55%

View all Comparables

Tharimmune, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Nov 6, 2025

View all Funding Rounds

Tharimmune, Inc. Investors

Notable investors and investment history

Tharimmune, Inc. investors
Investor	Rounds
Feynman Point Asset Management	Private Placement
Nima Capital	Private Placement
Polychain Capital	Private Placement
DRW Trading Group	Private Placement
Liberty City Ventures	Private Placement
7Ridge	Private Placement
Five North	Private Placement

View all Investors

Tharimmune, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Tharimmune, Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range8

Year Founded2017

Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?